DHILLON PUNIT sold SKYE

March 31, 2026 · Form 4 insider transaction

DHILLON PUNIT sold 250,000 shares of Skye Bioscience, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
250,000
Price
N/A
Total value
N/A
Role—
SecurityStock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged.; The stock option is fully vested.

View the original Form 4 on SEC EDGAR